安氟烷市场：按给药途径、最终用途划分 - 全球预测 2025-2030

2023年安氟醚市值为2.0639亿美元，预计到2024年将达到2.157亿美元，复合年增长率为4.59%，预计到2030年将达到2.827亿美元。

安氟醚是一种吸入性麻醉剂，主要用于外科手术，并在多项医疗和技术进步的影响下展现出动态的市场概况。儘管安氟烷具有广泛的适应症，但由于新型、更安全的麻醉剂的出现，其使用已受到一定限制。儘管有这些限制，在特定麻醉剂的成本和需求相容的情况下，安氟烷可能会发挥作用。它因其低成本和低功耗而至关重要，并且在需要快速麻醉起效和恢復的手术室中发挥重要作用。市场驱动因素包括全球外科手术数量的增加，特别是在预算限制导致麻醉剂选择较便宜的新兴国家。医疗基础设施的扩建和手术数量的增加可能会增加对安氟烷市场的需求。然而，SEVOFLURANE和DESFLURANE等新药的竞争加剧、对环境影响的担忧以及潜在的副作用等限制因素给广泛使用带来了挑战。儘管如此，输送机制的创新和改进的配方可能会缓解其中一些挑战，从而提供一个潜在的研究领域。汽化器技术和精密输送系统的增强可以减少剂量和副作用，并平衡功效和安全性。此外，透过适当的废弃物管理来最大限度地减少环境影响的持续研究正在为市场扩张开闢新的途径。因此，虽然安氟烷市场在成熟地区有些停滞，但对新兴市场的策略投资和环保实践的开拓提供了强劲的成长途径。由于竞争格局和利基市场，公司必须专注于有针对性的部署并策略性地驾驭监管环境以优化成长潜力。

市场动态：揭示快速发展的安氟烷市场的关键市场洞察

安氟醚市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

• 市场驱动因素
  • 世界各地慢性病和事故的增加
  • 麻醉师越来越喜欢使用安氟烷进行需要短期至中期麻醉的手术
• 市场限制因素
  • 更新、更先进的麻醉剂的出现
• 市场机会
  • 麻醉诱导和监测技术的创新
  • 持续寻找生物分解性且环保的替代品
• 市场问题
  • 安氟烷使用的监管监测和严格指南

波特五力：驾驭安氟烷市场的策略工具

波特的五力框架是了解安氟烷市场竞争格局的关键工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解外部对安氟醚市场的影响

外部宏观环境因素在影响安氟醚市场的表现动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析：了解安氟醚市场的竞争格局

安氟烷市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示自己的竞争定位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：安氟烷市场供应商绩效评估

FPNV定位矩阵是评估安氟醚市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製安氟醚市场的成功之路

安氟烷市场的策略分析对于旨在加强其全球市场影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1.市场渗透率：对当前市场环境的详细审查，主要企业的广泛资料，评估他们在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3. 塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

• 市场动态
  • 促进因素
    • 全球慢性病和事故的发生率正在增加
    • 安氟烷越来越受到麻醉师用于需要短期至中期麻醉的手术的青睐
  • 抑制因素
    • 新型先进麻醉剂的出现
  • 机会
    • 麻醉管理和监测技术的创新
    • 正在进行生物分解性和环保替代品的研究
  • 任务
    • 安氟烷使用的监管监测和严格指南
• 市场区隔分析
  • 给药途径：经由吸入增加安氟醚的剂量
  • 最终用途：医院使用安氟烷方式的演变
• 波特五力分析
• PESTEL分析
  • 政治
  • 经济
  • 社会
  • 科技
  • 法律
  • 环境

第六章 安氟醚市场：依给药途径

• 介绍
• 吸入
• 口服

第七章 安氟醚市场：依最终用途

• 介绍
• 门诊手术中心
• 医院

第八章 美洲安氟烷市场

• 介绍
• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美国

第九章亚太地区安氟烷市场

• 介绍
• 澳洲
• 中国
• 印度
• 印尼
• 日本
• 马来西亚
• 菲律宾
• 新加坡
• 韩国
• 台湾
• 泰国
• 越南

第十章 欧洲、中东和非洲安氟烷市场

• 介绍
• 丹麦
• 埃及
• 芬兰
• 法国
• 德国
• 以色列
• 义大利
• 荷兰
• 奈及利亚
• 挪威
• 波兰
• 卡达
• 俄罗斯
• 沙乌地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公国
• 英国

第十一章竞争格局

• 2023 年市场占有率分析
• FPNV 定位矩阵，2023
• 竞争情境分析
  • SunMed 完成对 Viair Medical 呼吸和麻醉耗材业务的收购
• 战略分析和建议

公司名单

• AbbVie Inc.
• Baxter International, Inc.
• Boehringer Ingelheim International GmbH
• Dragerwerk AG & Co. KGaA
• GE HealthCare Technologies Inc.
• Hikma Pharmaceuticals PLC
• J&TEC CO., LTD.
• Sanofi SA

The Enflurane Market was valued at USD 206.39 million in 2023, expected to reach USD 215.70 million in 2024, and is projected to grow at a CAGR of 4.59%, to USD 282.70 million by 2030.

Enflurane, an inhalational anesthetic agent used primarily during surgical procedures, presents a dynamic market profile influenced by several medical and technological advancements. The scope of its application is broad, but its use has been somewhat restricted due to the emergence of newer anesthetics with superior safety profiles. Despite these limitations, enflurane finds relevance in settings where cost considerations and specific anesthetic requirements align. It is essential for its low cost and potency, and serves critical roles in operating rooms where rapid onset and recovery are necessary. The market insights reveal key growth drivers including the rising number of surgeries globally, especially in emerging economies where budget constraints prompt consideration of less expensive anesthetic options. Opportunities lie prominently in expanding healthcare infrastructure and increasing surgical volumes which can boost the enflurane market demand. However, the market grapples with limitations such as heightened competition from newer agents like sevoflurane and desflurane, concerns regarding environmental impact, and potential adverse effects, which pose challenges to its widespread adoption. Despite these, innovations in delivery mechanisms and improved formulations could mitigate some of these challenges, offering potential areas for research. Enhanced vaporizer technologies and precision delivery systems could reduce dosage requirements and side effects, balancing efficacy and safety. Further, ongoing research into minimizing environmental impact through proper waste management practices provides additional pathways for market expansion. Thus, while enflurane's market is somewhat static in mature regions, strategic investments in emerging markets and the development of greener practices present substantial avenues for growth. As the market's nature is competitive yet niche, it is vital for businesses to emphasize targeted developments and to strategically navigate regulatory landscapes to optimize growth potential.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Enflurane Market

The Enflurane Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising incidences of chronic diseases and accidents globally
  • Increasing preference for enflurane among anesthesiologists for surgeries requiring short- to medium-term anesthesia
• Market Restraints
  • Emergence of newer and advanced anesthetic agents
• Market Opportunities
  • Technological innovations in anesthesia delivery and monitoring techniques
  • Ongoing research into biodegradable, eco-friendly alternatives
• Market Challenges
  • Regulatory scrutiny and stringent guidelines governing the use of enflurane

Porter's Five Forces: A Strategic Tool for Navigating the Enflurane Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Enflurane Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Enflurane Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Enflurane Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Enflurane Market

A detailed market share analysis in the Enflurane Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Enflurane Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Enflurane Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Enflurane Market

A strategic analysis of the Enflurane Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Enflurane Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Baxter International, Inc., Boehringer Ingelheim International GmbH, Dragerwerk AG & Co. KGaA, GE HealthCare Technologies Inc., Hikma Pharmaceuticals PLC, J&TEC CO., LTD., and Sanofi S.A..

Market Segmentation & Coverage

This research report categorizes the Enflurane Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Route of Administration, market is studied across Inhalation and Oral.
• Based on End-Use, market is studied across Ambulatory Surgical Centers and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising incidences of chronic diseases and accidents globally
    • 5.1.1.2. Increasing preference for enflurane among anesthesiologists for surgeries requiring short- to medium-term anesthesia
  • 5.1.2. Restraints
    • 5.1.2.1. Emergence of newer and advanced anesthetic agents
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological innovations in anesthesia delivery and monitoring techniques
    • 5.1.3.2. Ongoing research into biodegradable, eco-friendly alternatives
  • 5.1.4. Challenges
    • 5.1.4.1. Regulatory scrutiny and stringent guidelines governing the use of enflurane
• 5.2. Market Segmentation Analysis
  • 5.2.1. Route of Administration: Increasing administration of enflurane via inhalation
  • 5.2.2. End-Use: Evolving usage of enflurane by hospitals
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Enflurane Market, by Route of Administration

• 6.1. Introduction
• 6.2. Inhalation
• 6.3. Oral

7. Enflurane Market, by End-Use

• 7.1. Introduction
• 7.2. Ambulatory Surgical Centers
• 7.3. Hospitals

8. Americas Enflurane Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Enflurane Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Enflurane Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
  • 11.3.1. SunMed Completes Acquisition Of Respiratory & Anesthesia Consumables Business Of Vyaire Medical
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AbbVie Inc.
• 2. Baxter International, Inc.
• 3. Boehringer Ingelheim International GmbH
• 4. Dragerwerk AG & Co. KGaA
• 5. GE HealthCare Technologies Inc.
• 6. Hikma Pharmaceuticals PLC
• 7. J&TEC CO., LTD.
• 8. Sanofi S.A.

LIST OF FIGURES

• FIGURE 1. ENFLURANE MARKET RESEARCH PROCESS
• FIGURE 2. ENFLURANE MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ENFLURANE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ENFLURANE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL ENFLURANE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL ENFLURANE MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL ENFLURANE MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS ENFLURANE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS ENFLURANE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES ENFLURANE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES ENFLURANE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ENFLURANE MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. ENFLURANE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ENFLURANE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ENFLURANE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ENFLURANE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL ENFLURANE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. ENFLURANE MARKET DYNAMICS
• TABLE 7. GLOBAL ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL ENFLURANE MARKET SIZE, BY INHALATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL ENFLURANE MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL ENFLURANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL ENFLURANE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. AMERICAS ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 14. AMERICAS ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 15. AMERICAS ENFLURANE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 16. ARGENTINA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 17. ARGENTINA ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 18. BRAZIL ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 19. BRAZIL ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 20. CANADA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 21. CANADA ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 22. MEXICO ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 23. MEXICO ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 24. UNITED STATES ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 25. UNITED STATES ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 26. UNITED STATES ENFLURANE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 27. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 28. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 29. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 30. AUSTRALIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 31. AUSTRALIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 32. CHINA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 33. CHINA ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 34. INDIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 35. INDIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 36. INDONESIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 37. INDONESIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 38. JAPAN ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 39. JAPAN ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 40. MALAYSIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 41. MALAYSIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 42. PHILIPPINES ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 43. PHILIPPINES ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 44. SINGAPORE ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 45. SINGAPORE ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 46. SOUTH KOREA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 47. SOUTH KOREA ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 48. TAIWAN ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 49. TAIWAN ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 50. THAILAND ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 51. THAILAND ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 52. VIETNAM ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 53. VIETNAM ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 54. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 55. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 56. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 57. DENMARK ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 58. DENMARK ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 59. EGYPT ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 60. EGYPT ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 61. FINLAND ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 62. FINLAND ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 63. FRANCE ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 64. FRANCE ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 65. GERMANY ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 66. GERMANY ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 67. ISRAEL ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 68. ISRAEL ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 69. ITALY ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 70. ITALY ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 71. NETHERLANDS ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 72. NETHERLANDS ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 73. NIGERIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 74. NIGERIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 75. NORWAY ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 76. NORWAY ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 77. POLAND ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 78. POLAND ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 79. QATAR ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 80. QATAR ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 81. RUSSIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 82. RUSSIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 83. SAUDI ARABIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 84. SAUDI ARABIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH AFRICA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH AFRICA ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 87. SPAIN ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 88. SPAIN ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 89. SWEDEN ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 90. SWEDEN ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 91. SWITZERLAND ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 92. SWITZERLAND ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 93. TURKEY ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 94. TURKEY ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 95. UNITED ARAB EMIRATES ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 96. UNITED ARAB EMIRATES ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 97. UNITED KINGDOM ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 98. UNITED KINGDOM ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 99. ENFLURANE MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 100. ENFLURANE MARKET, FPNV POSITIONING MATRIX, 2023